Author

Kui Guo

Institutions: Qingdao University, Chinese PLA General Hospital, Yuhuangding Hospital

Observed institutions: Qingdao University, Shandong University, Chinese PLA General Hospital, Yuhuangding Hospital, Qilu Hospital of Shandong University

ORCID: 0000-0002-3594-3901

Observed ORCID: 0000-0002-3594-3901

OpenAlex ID: A5084767748

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma

2021 · Xiaohong Ma, Tianyi Zhao, et al. · Cell Death and Disease · 58

ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma

2021 · Shuo Zhang, Kui Guo, et al. · Frontiers in Oncology · 29

ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL

2022 · Xiaohong Ma, Min Xia, et al. · Cell Death and Disease · 18

MGLL expression correlates with tumor immune microenvironment and serves as a potential biomarker in ovarian cancer

2026 · Kui Guo, Anli Xu, et al. · Asian Journal of Surgery

Stigmasterol glucoside attenuates RANKL-induced osteoclastogenesis and bone resorption by suppressing MAPK and STAT3 signaling pathways: an integrative pharmacological study

2026 · Yiwei Jiang, Zhiyu Jin, et al. · Journal of Molecular Histology

EEE1F1 could serve as a prognostic biomarker for patients with endometrial cancer: A comprehensive analysis by integrating bulk and single-cell sequencing

2024 · Jiayuan Yu, Kui Guo, et al. · Asian Journal of Surgery

Works count: 6

Citation count: 105

H-index: 3

I10-index: 3